Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form
Abstract Background The present research was aimed to develop a self-microemulsifying drug delivery system (SMEDDS) pellet to increase the dissolution rate and in vivo hypoglycemic effect of gliclazide. Gliclazide belongs to BCS class 2 and it exhibits dissolution rate-limited absorption. Thus, diss...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SpringerOpen
2020-05-01
|
| coleção: | Future Journal of Pharmaceutical Sciences |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s43094-020-00034-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
